Saturday 17 October 2026 Export MD’s income statement to Excel — free account

Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.

27.38 0.38 −1.37%

Follow MD

Alert me

Market cap: $2.3B
P/E: 13.1×
Fwd P/E: 11.3×
Dividend yield: —
F-score: 7/9
Altman Z: 2.05
Beneish M: −2.86
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 1.83

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	2	1	—	—	—	—	1	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 2,260.00

Revenue 1,950.63

Net Income 174.81

Free Cash Flow 228.61

Net Debt 180.05

Current Ratio 1.32

Debt/Equity 0.66

P/E ratio 13.10

Fwd P/E 11.30

P/S ratio 1.12

P/B ratio 2.47

Past 5Y EPS Growth —

This Y EPS Growth 15.09%

Next Y EPS Growth 3.99%

Next Y revenue growth 2.46%

Next 5Y EPS Growth 7.11%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 42.13%

10-year low 10-year high

P/S against its own 10 years 53.96%

10-year low 10-year high

P/B against its own 10 years 85.29%

10-year low 10-year high

EV/Sales against its own 10 years 39.92%

10-year low 10-year high

EV/FCF against its own 10 years 24.25%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	178	349	500	404
Receivables	280	273	242	239
Inventory	—	—	—	—
Other	12	5	9	7
	483	640	764	660

	2023	2024	2025	Q'26
Payables	351	399	420	302
ST’ Debt	15	21	27	186
Other	—	—	—	—
	389	434	459	502

Compound Annual Growth %

	10y	5y	3y
Sales	(3.66%)	1.99%	(0.99%)
Cash Flow	(3.03%)	5.79%	17.54%
Earnings	(6.85%)	0.00%	35.60%
Book Value	(9.83%)	2.98%	(0.97%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	476	488	—	—	—
’25	458	469	493	494	1,914
’24	495	504	511	502	2,013
’23	491	501	507	496	1,995
’22	482	486	490	514	1,972
’21	447	473	493	499	1,911
’20	441	415	461	417	1,734

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(130)	125	—	—	—
’25	(117)	137	137	114	271
’24	(125)	107	92	133	207
’23	(101)	89	80	69	137
’22	(97)	82	83	99	167
’21	(82)	54	61	44	77
’20	(142)	188	170	(12)	205

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(136)	124	—	—	—
’25	(121)	133	132	109	253
’24	(131)	100	86	130	185
’23	(108)	81	71	60	104
’22	(105)	76	76	90	137
’21	(91)	69	51	41	69
’20	(152)	181	165	(19)	176

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.36	0.49	—	—	—
’25	0.24	0.46	0.84	0.40	1.94
’24	0.05	(1.84)	0.23	0.36	(1.19)
’23	0.17	0.34	0.26	(1.50)	(0.73)
’22	(0.25)	0.32	0.37	0.36	0.79
’21	0.21	0.41	0.36	0.55	1.53
’20	(0.23)	(8.03)	(0.49)	(0.76)	(9.55)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	59.36	40.56	31.68	19.93	7.37	20.27	14.40	8.18	6.62	11.84	Analyst estimates 2026–2028 Powerpack
	High	76.96	72.13	63.04	38.89	27.90	35.67	28.02	17.30	16.41	24.99
People
People	Employees	7,400	7,675	7,625	5,165	5,600	5,000	5,250	5,170	4,305	4,315
	Revenue/emp, $m	0.43	0.42	0.23	0.34	0.31	0.38	0.38	0.39	0.47	0.44
Income, $m
Income, $m	Revenue	3,183	3,253	1,723	1,780	1,734	1,911	1,972	1,995	2,013	1,914
	Gross margin, %	32.47	28.27	29.31	28.27	25.91	26.85	23.68	21.13	22.57	25.80
	EBT	514	386	166	59	7	135	81	(48)	(101)	216
	EBT margin, %	16.14	11.85	9.65	3.30	0.41	7.08	4.13	(2.42)	(5.03)	11.31
	Net income	325	320	269	(1,498)	(796)	131	66	(60)	(99)	165
	Depreciation	94	84	29	32	36	36	37	37	33	23
Per share, $
Per share, $	Revenue	34.44	35.20	18.91	21.32	20.79	22.53	23.63	24.27	24.16	22.76
	Earnings	3.49	3.45	2.93	(17.94)	(9.55)	1.53	0.79	(0.73)	(1.19)	1.94
	Cash flow	4.80	5.53	3.44	4.28	2.45	0.90	2.00	1.67	2.48	3.22
	Capex	(0.42)	(0.28)	(0.19)	(0.23)	(0.35)	(0.09)	(0.36)	(0.41)	(0.26)	(0.22)
	Free cash flow	4.38	5.25	3.26	4.05	2.11	0.82	1.64	1.27	2.21	3.00
	Book value	29.87	33.18	33.89	17.95	8.97	10.57	10.68	10.33	9.18	10.30
	Shares, m	92	92	91	83	83	85	83	82	83	84
Valuation, ×
Valuation, ×	P/E	19.13	15.87	11.26	0.00	0.00	17.78	18.78	0.00	0.00	11.03
	P/S	1.94	1.56	1.74	1.00	1.20	1.21	0.64	0.39	0.54	0.94
	P/B	2.24	1.65	0.97	1.54	2.79	2.57	1.41	0.91	1.43	2.08
	EV/Sales	2.46	2.10	2.85	1.67	1.50	1.48	0.91	0.62	0.68	0.99
	EV/FCF	19.35	14.10	16.57	11.48	14.81	40.83	13.13	11.79	7.38	7.51
Cash, $m
Cash, $m	Operating cash flow	444	511	314	358	205	77	167	137	207	271
	Capex	(39)	(26)	(17)	(19)	(29)	(8)	(30)	(33)	(22)	(18)
	Free cash flow	405	485	297	338	176	69	137	104	185	253
Balance, $m
Balance, $m	Working capital	138	96	157	190	1,105	413	1	95	205	305
	Total debt	1,706	1,853	1,975	1,748	1,745	1,005	651	633	618	597
	Net debt	1,639	1,782	1,907	1,566	516	518	548	456	269	98
	Shareholders’ equity	2,761	3,066	3,088	1,499	748	897	892	849	765	866
Returns, %
Returns, %	ROA	6.57	5.72	4.55	(29.71)	(21.26)	4.31	2.62	(2.65)	(4.53)	7.52
	ROIC	8.12	5.86	3.11	3.50	4.85	8.97	7.50	0.35	(4.15)	13.55
	ROE	12.50	11.00	8.73	(65.30)	(70.90)	15.93	7.42	(6.94)	(12.28)	20.28

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ACHC Acadia Healthcare Company, Inc.	$2.9B	— (loss-making)	21.1×	−0.39% (below 0%: shrinking)	−63.64% (below 0%: shrinking)	+856.54% (above 0%: growing)	100.00%	10.14%	Compare
AVAH Aveanna Healthcare Holdings Inc.	$2.8B	9.5×	10.4×	+13.73% (above 0%: growing)	+46.15% (above 0%: growing)	+57.89% (above 0%: growing)	32.59%	11.93%	Compare
GRDN Guardian Pharmacy Services, Inc.	$2.5B	37.5×	39.5×	+2.16% (above 0%: growing)	+133.33% (above 0%: growing)	+60.83% (above 0%: growing)	22.75%	5.87%	Compare
BKD Brookdale Senior Living Inc.	$2.4B	— (loss-making)	— (loss-making)	−11.61% (below 0%: shrinking)	n/m	+533.14% (above 0%: growing)	29.94%	11.86%	Compare
MD Pediatrix Medical Group, Inc.	$2.3B	13.1×	11.3×	+4.04% (above 0%: growing)	+6.52% (above 0%: growing)	−6.56% (below 0%: shrinking)	27.16%	11.67%
ADUS Addus HomeCare Corporation	$2.2B	20.4×	14.9×	+8.01% (above 0%: growing)	+24.17% (above 0%: growing)	+81.74% (above 0%: growing)	32.21%	10.32%	Compare
SGRY Surgery Partners, Inc.	$1.9B	— (loss-making)	— (loss-making)	+2.75% (above 0%: growing)	n/m	−60.63% (below 0%: shrinking)	22.41%	12.78%	Compare
ASTH Astrana Health, Inc.	$1.9B	44.3×	29.7×	+48.52% (above 0%: growing)	+110.53% (above 0%: growing)	−67.74% (below 0%: shrinking)	10.70%	3.53%	Compare
ARDT Ardent Health, Inc.	$1.7B	21.7×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
Median of peers	$2.3B	21.7×	18.0×	+2.46%	+35.16%	+71.29%	31.07%	10.23%

All 55 Medical Care Facilities stocks →

Pediatrix Medical Group, Inc. (MD) key facts

Concern: Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
Pediatrix Medical Group, Inc. (MD) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
Net income was $165.4 million, or $1.94 per share (basic), a net margin of 8.64%.
As of October 16, 2026, MD traded at $27.38, a market capitalization of $2.3 billion.
At that price the stock trades at 13.1× trailing-twelve-month earnings and 1.1× sales; its P/E is higher than 42% of its own readings over the past ten years.
Return on equity was 20.3% and debt-to-equity 0.66.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.05 (grey zone) for fiscal 2025.